News & Training
Staburo news about trainings, events and more
Staburo presented @ workshop from the working group Pharmaceutical Research (APF)
Staburo presented @ workshop from the working group Pharmaceutical Research (APF) On November 27, Staburo Managing Director Dr. Hannes Buchner gave a talk at the 74th workshop of the APF (Arbeitsgruppe Pharmazeutische Forschung) of the Deutsche Region der...
Staburo @ the DIA Global Clinical Trial Disclosure & Data Transparency Conference 2020
Staburo @ the DIA Global Clinical Trial Disclosure & Data Transparency Conference 2020 Staburo participated in the 2020 Global Clinical Trial Disclosure & Data Transparency Conference hosted by the Drug Information Association (DIA) from the 16 - 18 November,...
Staburo @ working group pharmaceutical research (APF) workshop
Staburo @ working group pharmaceutical research (APF) workshop Staburo Managing Director Dr. Hannes Buchner will talk about “Estimands update: Summary of world-wide authority interaction” together with Kaspar Rufibach from Roche at the 74th Arbeitsgruppe...
Introduction to Statistics course
Introduction to Statistics online course Our first course “Introduction to Statistics course” will be a 2-day course 02-03 November 2020! The course, which takes place online, is about providing a solid foundation in Statistics through practical application and with...
Staburo launches “Staburo Academy”
Staburo GmbH launches “Staburo Academy” (www.staburo.de/academy/)! Staburo is specialized in Biostatistics, Statistical Programming and Data Science. We cover a wide range of statistical services and develop tailor-made client solutions.We love to share our...
Staburo Session @ GMDS & CEN-IBS 2020: Children and Career
Staburo @ conference of the GMDS & CEN-IBS 2020 Dr. Hannes Buchner, Managing Director from Staburo participated in this online Conference on 08 SEP 2020 and talked about the topic “Children and Career” together with Benjamin Hofner from PEI, Cornelia Kunz and...
Staburo supports research on the impact of coronavirus disease on methodological aspects of ongoing clinical trials
Staburo supports research on the impact of coronavirus disease on methodological aspects of ongoing clinical trials On behalf of Staburo, Josef Höfler and our former colleague Nicole Krämer submitted comments on the EMA’s draft guidance on “Points to consider on...
Post event: Anything new for oncology?
Post event: Anything new for oncology? Lately, Basel Biometric Section and EFSPI organized a webinar "Estimands addendum is final: Anything new for oncology?". You can find the program, the slides, a recording of the entire event, and a document that answers questions...
Staburo @ Joint EFSPI / BBS Webinar: Estimands addendum is final: Anything new for oncology?
Staburo @ Joint EFSPI / BBS Webinar: Estimands addendum is final: Anything new for oncology? We are very proud that Staburo's Managing Director Dr. Hannes Buchner will be a speaker and will talk about "Treatment switching: challenges, estimands, and estimators". All...
You need support in data science?
Memberships and awards
